Vera Therapeutics, Inc. (VERA:NASDAQ) closed at $26.75 on November 19, 2026, up 4.57% on the day. The stock trades 52.3% below its 52-week high of $56.05 and 6.7% above its 52-week low of $25.08. Over the past year, it lost 4.0%. Vera Therapeutics, Inc. is part of the Health Care sector.
In 252 trading sessions since November 19, 2025, VERA closed higher on 111 days (44%). Its best day was November 26, 2025 (+13.25%) and its worst was September 23, 2026 (-8.85%). The stock moved 10% or more in a single session 4 times.
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.
Find more stocks like VERA with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.